Track topics on Twitter Track topics that are important to you
Kala has completed enrollment in its Phase 3 clinical trial for its product candidate for the short-term treatment of dry eye disease.
The post Kala Announces Enrollment Completion of Trial for Dry Eye Disease appeared first on Investing News Network.
Original Article: Kala Announces Enrollment Completion of Trial for Dry Eye DiseaseNEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...